COMMON SEASONAL CONDITIONS
top searches in india

health-news
Childhood Obesity: Wegovy Cuts BMI By 10% In Children As Young As 6; What Are The Risks?
Novo Nordisk led trial found that Wegovy reduced BMI by at least 10% in nearly 80% of children aged 6 to under 12 with obesity. However, limited long-term safety data and concerns about appetite suppression, nutritional intake and childhood development raise questions about the use of semaglutide in younger children.
WHATSAPP WELLNESS
1229 people got benefited from WhatsApp WellnessEXPLORE BY AGE GROUP
